NASDAQ:MGLN

Magellan Health Stock Forecast, Price & News

$94.37
+0.13 (+0.14 %)
(As of 06/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$94.20
$94.42
50-Day Range
$93.86
$94.62
52-Week Range
$67.67
$95.43
Volume220,252 shs
Average Volume304,441 shs
Market Capitalization$2.47 billion
P/E Ratio6.20
Dividend YieldN/A
Beta1.22
30 days | 90 days | 365 days | Advanced Chart
Receive MGLN News and Ratings via Email

Sign-up to receive the latest news and ratings for Magellan Health and its competitors with MarketBeat's FREE daily newsletter.


Magellan Health logo

About Magellan Health

Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. In addition, the company provides services to managed care organizations, employers, third party administrators, state governments, and other government agencies, exchanges, brokers, and consultants. Magellan Health, Inc. was incorporated in 1969 and is headquartered in Phoenix, Arizona.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.67 out of 5 stars

Medical Sector

361st out of 2,102 stocks

Hospitals Industry

6th out of 9 stocks

Analyst Opinion: 1.2Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 3.1 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Magellan Health (NASDAQ:MGLN) Frequently Asked Questions

Is Magellan Health a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Magellan Health stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MGLN, but not buy additional shares or sell existing shares.
View analyst ratings for Magellan Health
or view top-rated stocks.

What stocks does MarketBeat like better than Magellan Health?

Wall Street analysts have given Magellan Health a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Magellan Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Magellan Health's next earnings date?

Magellan Health is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Magellan Health
.

How were Magellan Health's earnings last quarter?

Magellan Health, Inc. (NASDAQ:MGLN) issued its earnings results on Friday, April, 30th. The company reported $1.33 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.66 by $0.67. The company had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.14 billion. Magellan Health had a net margin of 8.49% and a trailing twelve-month return on equity of 2.84%. Magellan Health's revenue was up 3.5% compared to the same quarter last year. During the same period in the prior year, the company earned $1.15 EPS.
View Magellan Health's earnings history
.

How has Magellan Health's stock been impacted by COVID-19 (Coronavirus)?

Magellan Health's stock was trading at $53.88 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MGLN stock has increased by 75.1% and is now trading at $94.37.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for MGLN?

3 brokerages have issued twelve-month target prices for Magellan Health's stock. Their forecasts range from $90.00 to $95.00. On average, they expect Magellan Health's stock price to reach $93.33 in the next year. This suggests that the stock has a possible downside of 1.1%.
View analysts' price targets for Magellan Health
or view top-rated stocks among Wall Street analysts.

Who are Magellan Health's key executives?

Magellan Health's management team includes the following people:
  • Mr. Kenneth John Fasola, CEO & Director (Age 61, Pay $3.52M)
  • Mr. James Elmer Murray, Pres & COO (Age 67, Pay $1.92M)
  • Mr. David Patrick Bourdon, Chief Financial Officer (Age 52, Pay $1.13M)
  • Mr. David Haddock, Gen. Counsel & Sec. (Age 51, Pay $1.63M)
  • Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 40, Pay $1.32M)
  • Ms. Renie Shapiro Silver, SVP - Corp. Fin.
  • Mr. Darren P. Lehrich, Chief Investor Relations Officer (Age 49)
  • Mr. John E. Littel, Chief External Affairs Officer (Age 56)
  • Ms. Caskie Lewis-Clapper, Chief HR Officer (Age 56)
  • Mr. Jay Youell, Sr. VP of Sales - Health Plan & Insurance Markets

What is Kenneth J. Fasola's approval rating as Magellan Health's CEO?

31 employees have rated Magellan Health CEO Kenneth J. Fasola on Glassdoor.com. Kenneth J. Fasola has an approval rating of 83% among Magellan Health's employees.

Who are some of Magellan Health's key competitors?

What other stocks do shareholders of Magellan Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Magellan Health investors own include Energy Transfer (ET), General Motors (GM), NVIDIA (NVDA), The Boeing (BA), Netflix (NFLX), UnitedHealth Group (UNH), Broadcom (AVGO), Mastercard (MA), Ford Motor (F) and Overstock.com (OSTK).

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

Who are Magellan Health's major shareholders?

Magellan Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.54%), Dimensional Fund Advisors LP (6.54%), Victory Capital Management Inc. (3.55%), Versor Investments LP (2.90%), Alpine Associates Management Inc. (2.63%) and Millennium Management LLC (2.47%). Company insiders that own Magellan Health stock include James E Murray, Jeffrey N West and Mostafa Kamal.
View institutional ownership trends for Magellan Health
.

Which institutional investors are selling Magellan Health stock?

MGLN stock was sold by a variety of institutional investors in the last quarter, including Brown Advisory Inc., Victory Capital Management Inc., Renaissance Technologies LLC, Northern Trust Corp, Nuveen Asset Management LLC, Dimensional Fund Advisors LP, D. E. Shaw & Co. Inc., and Goldman Sachs Group Inc.. Company insiders that have sold Magellan Health company stock in the last year include Jeffrey N West, and Mostafa Kamal.
View insider buying and selling activity for Magellan Health
or view top insider-selling stocks.

Which institutional investors are buying Magellan Health stock?

MGLN stock was acquired by a variety of institutional investors in the last quarter, including Versor Investments LP, Alpine Associates Management Inc., Millennium Management LLC, Water Island Capital LLC, Polar Asset Management Partners Inc., CNH Partners LLC, Morgan Stanley, and Citigroup Inc..
View insider buying and selling activity for Magellan Health
or or view top insider-buying stocks.

How do I buy shares of Magellan Health?

Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Magellan Health's stock price today?

One share of MGLN stock can currently be purchased for approximately $94.37.

How much money does Magellan Health make?

Magellan Health has a market capitalization of $2.47 billion and generates $4.58 billion in revenue each year. The company earns $382.33 million in net income (profit) each year or $0.77 on an earnings per share basis.

How many employees does Magellan Health have?

Magellan Health employs 9,000 workers across the globe.

What is Magellan Health's official website?

The official website for Magellan Health is www.magellanhealth.com.

Where are Magellan Health's headquarters?

Magellan Health is headquartered at 4801 E. Washington Street, Phoenix AZ, 85034.

How can I contact Magellan Health?

Magellan Health's mailing address is 4801 E. Washington Street, Phoenix AZ, 85034. The company can be reached via phone at 800-642-1716 or via email at [email protected]


This page was last updated on 6/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.